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Cause of Fever in a Case with End-Stage Renal Disease:
Splenic Marginal Zone Lymphoma
Abstract: Splenic marginal zone lymphomas (SMZL) are rare tumors arising from B-cells, accounting for
approximately 1% of all lymphomas. An accompanying lymphoma is uncommon in patients who have chronic
renal failure and undergo hemodialysis. We present herein a 35-year-old male hemodialysis patient admitted
with fever, abdominal pain, and splenomegaly, diagnosed with SMZL. In our investigations in the English
literature, we did not observe any SMZL case among hemodialysis patients. Fever may emerge due to different
causes in chronic hemodialysis patients, primarily infections. In hemodialysis patients presenting with fever,
lymphoma and other malignant diseases should be considered.
Key Words: Splenic marginal zone lymphoma, hemodialysis patient, fever

Son Dönem Böbrek Yetmezlikli Bir Olguda Ateş Nedeni Olarak Splenik
Marjinal Zon Lenfoma
Özet: Splenik marjinal zon lenfomalar, B hücrelerinden kaynaklanan, tüm lenfomaların yaklaşık % 1’ini
oluşturan, nadir tümörlerdir. Kronik hemodiyaliz hastalarında lenfoma görülmesi seyrektir. Ateş, karın ağrısı
ve dalak büyüklüğü ile başvuran ve splenik marjinal zon lenfoma tanısı konulan 35 yaşında bir erkek
hemodiyaliz hastasını sunmayı amaçladık. Biz İngilizce literatürde daha önce hemodiyaliz hastalarında
gösterilmiş bir splenik marjinal zon lenfoma olgusuna rastlamadık. Hemodiyaliz hastalarında başta
enfeksiyonlar olmak üzere değişik nedenlerle ateş ortaya çıkabilir. Hemodiyaliz hastalarında ateş nedeni olarak
lenfomalar ve diğer malign hastalıklar da dikkate alınmalıdır.
Anahtar Sözcükler: Splenik marjinal zon lenfoma, hemodiyaliz hastası, ateş

Introduction
Splenic marginal zone lymphomas (SMZL) are rare tumors arising from B-cells,
accounting for approximately 1% of all lymphomas. This is a type of lymphoma
commonly observed in elderly individuals, and is often asymptomatic, presenting with
abdominal pain, splenomegaly, cytopenia, and generally a slow clinical course (1-5).
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SMZL was first described by Schmid et al. (6) as a low-grade B-cell lymphoma of the
spleen, characterized by a nodular infiltrate based on pre-existing white pulp follicles,
which are partly or completely overrun by the neoplastic cells.
Previous studies have suggested that the frequency of cancer is higher in patients
with end-stage renal disease (ESRD) than in the general population, but have not
established whether this increase is confined to certain cancers or to certain categories
of ESRD patients. On the other hand, an accompanying lymphoma is uncommon in
patients who have chronic renal failure and undergo hemodialysis (7-9). In our
investigations in the English literature, we did not observe any SMZL case among
hemodialysis patients. Therefore, we present a 35-year-old male hemodialysis patient
who admitted with fever, abdominal pain, and splenomegaly, and was diagnosed with
SMZL.
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Case Report
A 35-year-old male patient, who was on a hemodialysis
program for two months due to ESRD secondary to
chronic interstitial nephritis, was hospitalized with high
fever lasting for two days. The cause of fever was thought
to be catheter-related, as he had a hemodialysis catheter in
his jugular vein, and hence, blood samples were obtained
and cephazolin sodium 1 g 2x1 was administered. The
catheter was removed. The blood cultures obtained before
treatment yielded Staphylococcus aureus. The antibiotic
administered was sensitive, but he was administered
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vancomycin 1 g since there was no reduction in the fever.
Appropriate antibiotherapy was administered for
Escherichia coli that grew in the urine culture, the
specimen of which had been obtained on admission.
Control blood and urine cultures were negative. Fever was
not under control with this treatment. On physical
examination, there were multiple lymphadenopathies in
the axillary and inguinal regions, in addition to
hepatosplenomegaly. In the laboratory analyses, the
complete blood count revealed a hemoglobin level of 6.3
g/dl, a hematocrit of 20%, a white blood cell count of

Figure 1. Computed tomography of the abdomen shows multiple paraaortic conglomerated lymphadenopathies, large liver of 200 mm, extremely
large spleen 290 mm in size, necrotic infract areas in upper and lower poles of the spleen, hypodense lesions in the spleen, and 20 mmsized lymphadenopathy anterior to liver.
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7900 μL, and a platelet count of 176000 103/μL. The
white blood cell differential showed 76% neutrophils,
17% lymphocytes, 5% monocytes, 1% eosinophils, and
1% basophils. Blood urea nitrogen was 40 mg/dl (N: 520), creatinine: 5.5 mg/dl (N: 0.5-1.6), potassium: 4.8
mEq/L (N: 3.5-5.5), sodium: 143 mEq/L (N: 135-150),
calcium: 8.3 mg/dl (N: 8.5-10.5), AST: 23 U/L (N: 7-39),
ALT: 9 U/L (N: 2-40), glucose: 71 mg/dl (N: 70-110), LDH:
756 (N: 110-250), CRP: 0.5 (N: 0-0.5), and
parathormone: 108 pg/ml (N: 0-78). Salmonella, brucella,
thyroid function tests, vitamin B 12, folic acid, ferrum
parameters, hepatitis markers, and coagulation tests
revealed normal results. In ultrasonography,
hepatosplenomegaly and multiple lymphadenopathies of
varying sizes were observed adjacent to the aorta. In the
computerized tomography of the abdomen, hepatomegaly,
massive splenomegaly, and periportal and paraaortic
adenopathies of different sizes were absorbed. Left axillary
biopsies were performed twice. It was reported as reactive
lymphadenopathy. Bone marrow biopsy was reported as
normal. Another abdominal tomography was performed
due to persistence of severe abdominal pain. In addition to
the findings in the initial tomography, regions of infarct
were detected in the spleen (Figure 1). Splenectomy was
performed with diagnostic and therapeutic intentions.
Pathologic evaluation of the spleen was positive for splenic
marginal zone B-cell lymphoma (Figure 2). His fever
regressed following splenectomy and significant
improvement was observed in the clinical course. The
patient was then referred to a hematologist for
consultation, and we await his follow-up.
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Discussion
Fever may emerge due to different causes in chronic
hemodialysis patients, primarily infections. In
hemodialysis patients presenting with fever, lymphoma
and other malignant diseases should be considered (10).
In our investigations in the English literature, we did
not observe any SMZL case among hemodialysis patients.
In this hemodialysis patient presenting with high fever,
which continued despite resolution of the infection, we
considered that he had lymphoma based on other clinical
and laboratory findings; however, peripheral adenopathy
and bone marrow biopsies did not provide diagnostic
results. Pathological evaluation of splenectomy was
decided due to massive splenomegaly in both physical
examination and computerized tomography, which
revealed SMZL.
SMZL accompanying extranodal marginal zone B-cell
lymphoma of mucosa-associated lymphoid tissue (MALTlymphoma) and nodal marginal zone lymphoma comprise
the marginal-zone lymphoma group. SMZL is a newly
defined, separate clinicopathological entity. SMZL is a
disease involving the spleen, bone marrow and peripheral
blood as the initial manifestations of the disease.
Definitive diagnosis was possible only by laparotomy and
splenectomy. Because of the slow course of these types of
lymphomas, surgical treatment with splenectomy appears
to play an important role in the treatment of some
patients, with a resultant clinical response in most cases
(1,2,5,10).

Figure 2. Splenic marginal zone B-cell lymphoma (hematoxylin-eosin). (A,B) Histologically, the germinal center is surrounded by small lymphoid cells
that merge peripherally into slightly larger cells with pale-staining cytoplasm. Both the small lymphoid cells and larger cells are neoplastic.
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